Medtronic (MDT)
(Delayed Data from NYSE)
$88.26 USD
+0.49 (0.56%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $88.27 +0.01 (0.01%) 7:44 PM ET
3-Hold of 5 3
B Value C Growth F Momentum C VGM
Income Statements
Fiscal Year end for Medtronic PLC falls in the month of April .
All items in Millions except EPS data.
4/30/24 | 4/30/23 | 4/30/22 | 4/30/21 | 4/30/20 | |
---|---|---|---|---|---|
Sales | 32,364 | 31,227 | 31,686 | 30,117 | 28,913 |
Cost Of Goods | 11,216 | 10,719 | 10,145 | 10,483 | 9,424 |
Gross Profit | 21,148 | 20,508 | 21,541 | 19,634 | 19,489 |
Selling & Adminstrative & Depr. & Amort Expenses | 16,003 | 15,023 | 15,788 | 15,150 | 14,698 |
Income After Depreciation & Amortization | 5,145 | 5,485 | 5,753 | 4,484 | 4,791 |
Non-Operating Income | 412 | 515 | 318 | 336 | 356 |
Interest Expense | 719 | 636 | 553 | 925 | 1,092 |
Pretax Income | 4,837 | 5,364 | 5,517 | 3,895 | 4,055 |
Income Taxes | 1,133 | 1,580 | 456 | 265 | -751 |
Minority Interest | 28 | 26 | 22 | 24 | 17 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 3,704 | 3,784 | 5,061 | 3,630 | 4,806 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 3,677 | 3,758 | 5,040 | 3,606 | 4,789 |
Depreciation Footnote | 4/30/24 | 4/30/23 | 4/30/22 | 4/30/21 | 4/30/20 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 7,792 | 8,182 | 8,460 | 7,186 | 7,454 |
Depreciation & Amortization (Cash Flow) | 2,647 | 2,697 | 2,707 | 2,702 | 2,663 |
Income After Depreciation & Amortization | 5,145 | 5,485 | 5,753 | 4,484 | 4,791 |
Earnings Per Share Data | 4/30/24 | 4/30/23 | 4/30/22 | 4/30/21 | 4/30/20 |
---|---|---|---|---|---|
Average Shares | 1,330.20 | 1,332.80 | 1,351.40 | NA | 1,351.10 |
Diluted EPS Before Non-Recurring Items | 5.20 | 5.29 | 5.55 | 4.43 | 4.59 |
Diluted Net EPS (GAAP) | 2.76 | 2.82 | 3.73 | 2.66 | 3.54 |
Fiscal Year end for Medtronic PLC falls in the month of April .
All items in Millions except EPS data.
7/31/24 | 4/30/24 | 1/31/24 | 10/31/23 | 7/31/23 | |
---|---|---|---|---|---|
Sales | 7,915.00 | 8,589.00 | 8,089.00 | 7,984.00 | 7,702.00 |
Cost Of Goods | 2,761.00 | 3,045.00 | 2,782.00 | 2,761.00 | 2,628.00 |
Gross Profit | 5,154.00 | 5,544.00 | 5,307.00 | 5,223.00 | 5,074.00 |
SG&A, R&D, and Dept/Amort Expenses | 3,874.00 | 4,491.00 | 3,824.00 | 3,883.00 | 3,805.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 1,280.00 | 1,053.00 | 1,483.00 | 1,340.00 | 1,269.00 |
Non-Operating Income | 157.00 | 5.00 | 177.00 | 154.00 | 76.00 |
Interest Expense | 167.00 | 203.00 | 188.00 | 180.00 | 148.00 |
Pretax Income | 1,268.00 | 856.00 | 1,472.00 | 1,313.00 | 1,196.00 |
Income Taxes | 220.00 | 196.00 | 135.00 | 402.00 | 400.00 |
Minority Interest | 6.00 | 17.00 | 15.00 | 2.00 | -6.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 1,048.00 | 660.00 | 1,337.00 | 911.00 | 796.00 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 1,043.00 | 643.00 | 1,322.00 | 909.00 | 803.00 |
Earnings Per Share Data | 7/31/24 | 4/30/24 | 1/31/24 | 10/31/23 | 7/31/23 |
---|---|---|---|---|---|
Average Shares | 1,296.50 | 1,325.40 | 1,331.70 | 1,331.90 | 1,333.80 |
Diluted EPS Before Non-Recurring Items | 1.23 | 1.46 | 1.30 | 1.25 | 1.20 |
Diluted Net EPS (GAAP) | 0.80 | 0.50 | 0.99 | 0.68 | 0.59 |